Topiramate in the treatment of myoclonic-astatic epilepsy in children: A retrospective hospital audit

Journal of Postgraduate Medicine

Volumn 49, Issue 3, 2003, Pages 202-205

  Jayawant, S ^a   Libretto, S E ^b  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b Janssen Cilag Ltd   (United Kingdom)

Author keywords

Anti epileptic drugs; Epilepsy in children; Myoclonic Astatic Epilepsy; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; LAMOTRIGINE; PREDNISOLONE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ANOREXIA; ARTICLE; ATONIC SEIZURE; BODY WEIGHT DISORDER; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LETHARGY; MALE; MEDICAL AUDIT; MEDICAL RECORD; MYOCLONIC ASTATIC EPILEPSY; OUTPATIENT DEPARTMENT; RETROSPECTIVE STUDY; STEADY STATE; TREATMENT PLANNING;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; EPILEPSY, ABSENCE; FEMALE; FRUCTOSE; GREAT BRITAIN; HUMANS; MALE; MEDICAL AUDIT; MYOCLONIC EPILEPSY, JUVENILE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0344688416     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Camfield P, Camfield C. Epileptic syndromes in childhood: Clinical features, outcomes, and treatment. Epilepsia 2002;43:27-32.
2. Doose H, Baier WK. Epilepsy with primary generalized myoclonic-astatic seizures: a genetically determined disease. Eur J Pediatr 1987;146:550-4.
3. Proposal for revised classification of epilepsy and epileptic syndromes. Commission on classification and terminology of the International League Against Epilepsy. Epilepsia 1989;30:389-99.
4. Neito-Barrera M, Candau R, Nieto-Jimenez M, Correa A, del Portal LR. Topiramate in the treatment of severe myoclonic epilepsy in infancy. Seizure 2000;9:590-4.
5. Guerrini R, Belmonte A, Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia 1998;39;S2-10.
6. Wakai S, Ito N, Sucoka H, Kawamoto Y, Hayasaka H, Chiba S. Severe myoclonic epilepsy in infancy and carbamazepine. Eur J Pediatr 1996;155:724.
7. Genton P, Gelisse P, Thomas P, Dravet C. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 2000;55:1106-9.
8. Perucca E. The spectrum of the new Antiepileptic drugs. Acta Neurol Belg 1999;99:231-8.
9. Chiron C, Marchand MC, Tran A, Rey E, d'Athis P, Vincent J, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomized placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 2000;356:1638-42.
10. Wallace SJ. Newer antiepileptic drugs: advantages and disadvantages. Brain Dev 2001;23:277-83.
11. Rogawski MA, Porter RJ. Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 1990;42:223-86.
12. Glauser TA. Topiramate. Semin Pediatric Neurol 1997;4:43-42.
13. Rosenfeld WE, Sachdeo RC, Faught RE, Privitera M. Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment. Epilepsia 1997;38:S34-6.
14. Sachdeo RC, Reife RA, Lim P, Pledger G. Topiramate monotherapy for partial onset seizures. Epilepsia 1997;38:294-300.
15. Sachdeo RC, Glauser TA, Ritter FJ, Reife R, Lim P, Pledger G. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 1999;52:1882-7.
16. Glauser TA, Clark PO, Strawsburg R. A pilot study of topiramate in the treatment of infantile spasms. Epilepsia 1998;39:1324-8.
17. Mikaeloff Y, de Saint-Martin A, Mancini J, Peudenier S, Pedespan JM, Vallee L et al. Topiramate: efficacy and tolerability in children according to epilepsy syndromes. Epilepsy Res 2003;53:225-32.
18. Genton P. When antiepileptic drugs aggravate epilepsy. Brain Dev 2000;22:75-80.